Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure

NCT02926703 is registered in ClinicalTrials.gov with RWTH Aachen University as lead sponsor.

NCT NCT02926703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02926703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure
Lead sponsor
RWTH Aachen University
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
August 31, 2016
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seizure, syncope